The levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in the serum were measured to investigate the ability of the selected CFSs to reduce the level of pro-inflammatory cytokines in mice with DSS-induced colitis (Figure 5). The gene discussed is IL6; the disease is colitis.